RxDoctor Payments Data

Laura Glaser, MD

Obstetrics & Gynecology · Chicago, ILNPI 1083974885

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $13,855 of the $14,719 with a category attached, or 94.1%. 9 manufacturers reported payments, led by Pfizer at 45.9% of the total. Reporting peaked in 2022 at $10,345 and has fallen 98.6% since, to $142 in 2025. Among obstetrics & gynecology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,719in general payments, 2019–2025

Across 17 payments — averaging $865.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$7K
  • Myovant Sciences Inc.$4K
  • Sumitomo Pharma America, Inc.$4K
  • Medical Device Business Services, Inc.$345
  • Applied Medical Resources Corporation$175
  • Hologic Sales And Service, LLC$111
  • plus $150 from 3 others

What the payments were for

  • Consulting fees$1751%
  • Speaking & faculty fees$13,85594%
  • Food & beverage$3642%
  • Education$3252%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,719 in reported general payments places this provider in the 95th percentile of 1,732 obstetrics & gynecology providers in Illinois.

See all obstetrics & gynecology providers in Illinois

Medicare billing

Part B allowed, 2024
$11,354
Medicare patients
69
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol50$3,199
Clobetasol Propionate13$1,001
ValacyclovirValacyclovir Hcl11$261
Medroxyprogesterone Acetate19$235
Fluconazole14$105

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →